Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. But as Peter Lynch said in One Up On Wall ...

"BioSyent is a Canadian success story. During the last five years to 2024, BioSyent has launched 7 new products in Canada, grown its revenue by 64%, its net profit by 66% and doubled its EPS while ...

Pursuant to the SPA, BioSyent will acquire from the shareholders of Oral Science (the "Sellers”), in an arm’s length transaction, 100% of the issued and outstanding shares of Oral Science Inc. for a ...

(RTTNews) - BioSyent Inc. (BIOYF, RX.V) has entered into a Share Purchase Agreement to acquire Oral Science Inc., a privately-owned Canadian dental company, for $25.5 million, in a share and cash deal ...

TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- This press release is being disseminated as required by National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting ...

Completed acquisition of Oral Science Inc., a Canadian owner and distributor of specialized dental hygiene and oral health products, as announced on March 2, 2026 Additional sales and EBITDA of $2,984 ...

MISSISSAUGA, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc.

For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk of stock picking is that you will likely buy under-performing companies. We ...

MISSISSAUGA, Ontario, April 30, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2025 Bloom Burton & Co.